Cytoki Pharma

Health

“Cytoki Pharma Reports Positive Early-Stage Data for CK-0045 in Type 2 Diabetes and Obesity”

Cytoki Pharma announced promising initial findings on Tuesday for its investigational lipidated IL-22 analogue, CK-0045, bolstering its prospects for further…

Read More »
Back to top button